Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes
2000
Studying How Tumor Cells Present Antigens for Immunotherapy
publication
Evidence: moderate
Author Information
Author(s): Spierings D C J, Agsteribbe E, Wilschut J, Huckriede A
Primary Institution: University of Groningen
Hypothesis
Can the antigen-presenting capabilities of neuroblastoma cells be effectively evaluated using influenza virus-specific cytotoxic T lymphocytes?
Conclusion
Neuroblastoma cells can present antigens effectively, making them a suitable target for immunotherapy.
Supporting Evidence
- The study demonstrated that neuroblastoma cells can present antigens effectively despite low MHC class I expression.
- Influenza-specific CTLs were able to efficiently lyse the infected neuroblastoma cells.
- The findings suggest that neuroblastoma is a suitable target for immunotherapy.
Takeaway
This study shows that certain tumor cells can still be recognized and attacked by the immune system, which is good news for cancer treatment.
Methodology
The study used immunofluorescence analyses to evaluate the expression of MHC class I molecules in neuroblastoma cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website